{"id":859194,"date":"2025-06-10T13:11:16","date_gmt":"2025-06-10T17:11:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/"},"modified":"2025-06-10T13:11:16","modified_gmt":"2025-06-10T17:11:16","slug":"levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/","title":{"rendered":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, June  10, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>UroGen Pharma Ltd.<\/strong> (&#8220;UroGen Pharma Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: URGN) of a class action securities lawsuit.<\/p>\n<p align=\"left\">\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vuLB0IJiU-P7I_z2paEwusW81AbOAKtvqUgj91rReQBut5xGZlYHryMdv2V82rf3l6EAkSMrf8CrGd0pP4DkzrNWUQh0MYedhmq1OxdqC6jKxoUOux54I4Rg9Vx4lw1dFvvbmC4a5W8aC86vJEVliysXNEBDLxe9D4Ha8F2EX7e0FTFrqiidpdNoYGkszC3hWzv8uKt6vXIA1zXmes4u0XNjXADGKCVNwlBppNOo1Mr9NQojOUKo7U4nHR5BbJuvcFqh3HcroLaBg-_yAyq2mA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/urogen-pharma-ltd-lawsuit-submission-form?prid=152248&amp;wire=3<\/a>\n      <\/p>\n<p align=\"left\">\n        <strong>URGN<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=khnpHyhYlWCTafpD06GMCEE23pxoKOL67jDQy87lDoDH4ciSTrPELPiQowWAdzSrTtfvHNafp_F9_KNBImVvMDbYLMXD6tKQExfbSvudK4I=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p align=\"left\">\n        <strong>CASE DETAILS: <\/strong>The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the ENVISION clinical study was not designed to demonstrate substantial evidence of effectiveness of the Company\u2019s lead pipeline product, UGN-102, because it lacked a concurrent control arm; (2) as a result, the Company would have difficulty demonstrating that the duration of response endpoint was attributable to UGN-102; (3) UroGen failed to heed the FDA\u2019s warnings about the study design used to support a drug application for UGN-102; (4) as a result of the foregoing, there was a substantial risk that the NDA for UGN-102 would not be approved; and (5) as a result of the foregoing, defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p align=\"left\">\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in UroGen Pharma Ltd. during the relevant time frame, you have until <strong>July 28, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p align=\"left\">\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p align=\"left\">\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p align=\"left\">\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=khnpHyhYlWCTafpD06GMCEE23pxoKOL67jDQy87lDoAo-rCn9rtGc-5VFC1W5sU__G1ia1n-_ZOHSysUaLVRP3sjouJZkH5h1758BxXno0M=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9lWxLaWkEsCid7jozZm_Pc4o5whfun7Nj2yQj3KnwLzuDm87796KLVIqKIo4c6eCvFPIuwoJBt7GoYOZ3uNbjg==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2ZhZWRmNGYtZGFkMS00M2YzLTk0MGQtNmIzZjJlNDg5MzE4LTEwMzIyOTMtMjAyNS0wNi0xMC1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in UroGen Pharma Ltd. (&#8220;UroGen Pharma Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: URGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/urogen-pharma-ltd-lawsuit-submission-form?prid=152248&amp;wire=3 URGN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the ENVISION clinical study was not designed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-859194","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in UroGen Pharma Ltd. (&#8220;UroGen Pharma Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: URGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/urogen-pharma-ltd-lawsuit-submission-form?prid=152248&amp;wire=3 URGN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the ENVISION clinical study was not designed &hellip; Continue reading &quot;Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T17:11:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN\",\"datePublished\":\"2025-06-10T17:11:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/\"},\"wordCount\":444,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/\",\"name\":\"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\",\"datePublished\":\"2025-06-10T17:11:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/","og_locale":"en_US","og_type":"article","og_title":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk","og_description":"NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in UroGen Pharma Ltd. (&#8220;UroGen Pharma Ltd.&#8221; or the &#8220;Company&#8221;) (NASDAQ: URGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/urogen-pharma-ltd-lawsuit-submission-form?prid=152248&amp;wire=3 URGN investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (1) the ENVISION clinical study was not designed &hellip; Continue reading \"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-10T17:11:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN","datePublished":"2025-06-10T17:11:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/"},"wordCount":444,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/","name":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=","datePublished":"2025-06-10T17:11:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTU4OSM2OTgyMzEwIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-urogen-pharma-ltd-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-july-28-2025-urgn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi &amp; Korsinsky Reminds UroGen Pharma Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 \u2013 URGN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=859194"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859194\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=859194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=859194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=859194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}